Company Short-Term Debts: Erasca (ERAS)

Graphic logo of Erasca, Inc. (ERAS)

The market valuation dynamics for Erasca, Inc. (ERAS) demonstrate the current indicator 0.00. The Erasca, Inc. (ERAS) business is based on the development of oncology treatments, minimizing risks by creating a family of drugs for various types of neoplasms. Growth potential relies on the shortage of targeted solutions to combat cell resistance, which ensures steady interest from leading medical centers and the expansion of the partner network.

Company Short-Term Loans and Borrowings: Erasca Inc (ERAS) for 07/04/2022 - 10/28/2026

ERAS (Erasca Oncology): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Erasca|ERAS - Consensus Target
- market capitalization data:
Market Capitalization Erasca, Inc.|ERAS - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Erasca|ERAS - Accounting Value of Company|Market Cap to Net Assets Ratio erasca.com|ERAS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Erasca, Inc.|ERAS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Erasca, Inc.|ERAS - Company Aggregate Debts|Debt to Book Capitalization Ratio Erasca, Inc.|ERAS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Erasca
Fundamental company valuation:ERAS Erasca
Flagship merchandise of erasca.com

This indicator measures the volume of liabilities with maturities of up to one year, determining the risk of a cash flow gap. The metric assesses the business's ability to service current loans without compromising operational activities. Amid the scientific race of Erasca, Inc. (ERAS) to develop anti-cancer molecules, an excessive burden could limit the pace of clinical trials. By analyzing the short-term debt balance, an investor can see the issuer's liquidity dynamics. An upward trend in the curve signals a potential threat to the portfolio's financial stability.

Competitors of Erasca, Inc. (ERAS)

ONC: Company Short-Term Debts|HALO - Company Current Liabilities|Company Short-Term Debts RVMD|AAPG (Ascentage Pharma Corp) - Short-Term Debt|CGON - Company Short-Term Debt|Company Short-Term Loans and Borrowings urogen.com (URGN)|Bicara Therapeutics (BCAX) - Company Current Liabilities|Company Short-Term Loans and Borrowings Personalis Inc (PSNL)|Delcath - Company Short-Term Debts|YMAB - Company Current Liabilities|Aura Biosciences, Inc. - Company Current Liabilities|CADL: Company Short-Term Debts|Company Short-Term Debt Accuray ARAY|SELLAS Life Sciences Group (SLS) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ACTU (Actuate Therapeutics, Inc)|Short-Term Debt Citius Oncology Inc|TuHURA Biosciences, Inc. - Company Short-Term Debts|Short-Term Debt TARA (protaratx.com)|Company Short-Term Debt Fate Therapeutics|Company Short-Term Loans and Borrowings Aadi Bioscience, Inc. WHWK|TScan - Company Short-Term Debts|CSBR: Company Short-Term Debts|xbiotech.com - Company Short-Term Debt|CEL-SCI (CVM) - Short-Term Debt Volume|Company Short-Term Debts OSTX|Company Current Liabilities Radiopharm Theranostics Ltd|Company Short-Term Debts ARTV|Company Short-Term Debts adlainortye.com ANL|Company Current Liabilities Veru Inc.|Company Short-Term Loans and Borrowings tempesttx.com TPST|Company Short-Term Debts XLO (Xilio)|RENB: Short-Term Debt Volume|Company Short-Term Debt muraloncology.com|Kairos Pharma (KAPA) - Company Short-Term Indebtedness|Company Short-Term Debts OKUR|Company Current Liabilities CytoMed (GDTC)|CRIS (Curis, Inc.) - Company Current Liabilities|Short-Term Debt Volume apollomicsinc.com (APLM)|THAR: Company Short-Term Debts|Advanced Biomed Inc. - Short-Term Debt|Company Short-Term Debt Genprex, Inc. (GNPX)|CLDI - Company Short-Term Loans and Borrowings|SBFM: Company Short-Term Debts|XBIO (Xenetic Biosciences, Inc.) - Company Short-Term Debts|SLRX: Company Short-Term Debt|Short-Term Debt Volume Kitov Pharma|Company Short-Term Debts AONC (American Oncology Network)|Company Current Liabilities beigene.com (BGNE)|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. - Company Short-Term Debts|iCAD Corp (ICAD) - Company Short-Term Debt|IKNA - Company Short-Term Indebtedness|NTBL (Notable Labs, Ltd.) - Company Short-Term Debts|Viracta Therapeutics, Inc. (VIRX) - Company Current Liabilities|Company Short-Term Debts MOR (MorphoSys)|Short-Term Debt NAYA|Ascentage Pharma Group Ltd (AAPGV) - Company Short-Term Debt